Market Research Reports and Industry Reports

Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

“Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015" provides an overview of Auto-Immune Diseases currently in pipeline stage.
 

 The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases pipeline products.
 
 This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.
 
 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
 
 Scope
 
 – Extensive coverage of the Auto-Immune Diseases under development
 
 – The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
 
 – The report reviews the major players involved in the development of Auto-Immune Diseases and list all their pipeline projects
 
 – The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
 
 – The report provides key clinical trial data of ongoing trials specific to pipeline products
 
 – Recent developments in the segment / industry
 
 Reasons To Buy
 
 The report enables you to:
 
 Formulate significant competitor information, analysis, and insights to improve R&D strategies
 Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 Identify and understand important and diverse types of Auto-Immune Diseases under development
 Develop market-entry and market expansion strategies
 Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
 In-depth analysis of the product’s current stage of development, territory and estimated launch date

 2 Introduction 19
 
 2.1 Auto-Immune Diseases Overview 19
 
 3 Products under Development 20
 
 3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development 20
 
 3.2 Auto-Immune Diseases - Pipeline Products by Territory 21
 
 3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path 22
 
 3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 23
 
 4 Auto-Immune Diseases - Pipeline Products under Development by Companies 24
 
 4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 24
 
 4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development 28
 
 5 Auto-Immune Diseases Companies and Product Overview 35
 
 5.1 Adaptive Biotechnologies Corporation Company Overview 35
 
 5.1.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
 
 5.2 Agena Bioscience, Inc Company Overview 37
 
 5.2.1 Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 37
 
 5.3 Albert-Ludwigs-Universitat Freiburg Company Overview 38
 
 5.3.1 Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 38
 
 5.4 Alere Inc. Company Overview 40
 
 5.4.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
 
 5.5 Amarantus Bioscience Holdings, Inc. Company Overview 42
 
 5.5.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
 
 5.6 Amdix B.V. Company Overview 44
 
 5.6.1 Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 44
 
 5.7 Analyticon Biotechnologies AG Company Overview 46
 
 5.7.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 46
 
 5.8 apDia n.v. Company Overview 47
 
 5.8.1 apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview 47
 
 5.9 Autoimmune Technologies, LLC Company Overview 48
 
 5.9.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
 
 5.10 Beckman Coulter, Inc. Company Overview 52
 
 5.10.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
 
 5.11 BG Medicine, Inc. Company Overview 54
 
 5.11.1 BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
 
 5.12 Biocortech Company Overview 56
 
 5.12.1 Biocortech Pipeline Products & Ongoing Clinical Trials Overview 56
 
 5.13 Biogen, Inc. Company Overview 57
 
 5.13.1 Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
 
 5.14 Biomedal S.L. Company Overview 59
 
 5.14.1 Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview 59
 
 5.15 Biomerica, Inc. Company Overview 62
 
 5.15.1 Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
 
 5.16 Bionure Farma, S.L. Company Overview 65
 
 5.16.1 Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview 65
 
 5.17 Bio-Rad Laboratories, Inc. Company Overview 66
 
 5.17.1 Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
 
 5.18 BioRap Technologies Ltd. Company Overview 68
 
 5.18.1 BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
 
 5.19 Boston University Company Overview 69
 
 5.19.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 69
 
 5.20 CareDx, Inc. Company Overview 70
 
 5.20.1 CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
 
 5.21 CD Diagnostics, Inc. Company Overview 72
 
 5.21.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
 
 5.22 Chronix Biomedical, Inc. Company Overview 73
 
 5.22.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
 
 5.23 Co-Diagnostics HBDC, Inc. Company Overview 75
 
 5.23.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
 
 5.24 Crescendo Bioscience, Inc. Company Overview 76
 
 5.24.1 Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
 
 5.25 Digna Biotech, S.L. Company Overview 79
 
 5.25.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 79
 
 5.26 Durin Technologies, Inc. Company Overview 82
 
 5.26.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
 
 5.27 Enterome Bioscience SA Company Overview 83
 
 5.27.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 83
 
 5.28 Ezose Sciences Inc. Company Overview 85
 
 5.28.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
 
 5.29 Flamentera AG Company Overview 87
 
 5.29.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 87
 
 5.30 Genalyte, Inc. Company Overview 88
 
 5.30.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
 
 5.31 Genentech, Inc. Company Overview 90
 
 5.31.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
 
 5.32 GeNeuro SA Company Overview 92
 
 5.32.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 92
 
 5.33 Glycominds Ltd. Company Overview 94
 
 5.33.1 Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview 94
 
 5.34 Grifols, S.A. Company Overview 95
 
 5.34.1 Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview 95
 
 5.35 Hannover Medical School Company Overview 97
 
 5.35.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 97
 
 5.36 Helmholtz Centre for Infection Research Company Overview 98
 
 5.36.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 98
 
 5.37 HOB Biotech Group Co., Ltd. Company Overview 99
 
 5.37.1 HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 99
 
 5.38 Hospital for Special Surgery Company Overview 100
 
 5.38.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 100
 
 5.39 Hycor Biomedical Inc. Company Overview 101
 
 5.39.1 Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
 
 5.40 Ignyta, Inc. Company Overview 103
 
 5.40.1 Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
 
 5.41 ImmusanT, Inc. Company Overview 106
 
 5.41.1 ImmusanT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
 
 5.42 Innobiochips Company Overview 107
 
 5.42.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview 107
 
 5.43 INOVA Diagnostics, Inc. Company Overview 108
 
 5.43.1 INOVA Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
 
 5.44 Institut National de la Sante et de la Recherche Medicale Company Overview 115
 
 5.44.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 115
 
 5.45 Is Diagnostics Company Overview 117
 
 5.45.1 Is Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 117
 
 5.46 LineaGen, Inc. Company Overview 118
 
 5.46.1 LineaGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
 
 5.47 Lophius Biosciences GmbH Company Overview 119
 
 5.47.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 119
 
 5.48 Louisville Bioscience, Inc. Company Overview 121
 
 5.48.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
 
 5.49 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Company Overview 125
 
 5.49.1 Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview 125
 
 5.50 Medica Corporation Company Overview 127
 
 5.50.1 Medica Corporation Pipeline Products & Ongoing Clinical Trials Overview 127
 
 5.51 Metabolomic Technologies Inc. Company Overview 130
 
 5.51.1 Metabolomic Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
 
 5.52 Metanomics Health GmbH Company Overview 133
 
 5.52.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 133
 
 5.53 MSDx, Inc. Company Overview 135
 
 5.53.1 MSDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
 
 5.54 Myriad Genetics, Inc. Company Overview 139
 
 5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
 
 5.55 Nanosphere, Inc. Company Overview 141
 
 5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141
 
 5.56 Neuro Vigor, LLC Company Overview 143
 
 5.56.1 Neuro Vigor, LLC Pipeline Products & Ongoing Clinical Trials Overview 143
 
 5.57 Northwestern University Company Overview 144
 
 5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 144
 
 5.58 NoToPharm s.r.l. Company Overview 146
 
 5.58.1 NoToPharm s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 146
 
 5.59 NOWDiagnostics Company Overview 151
 
 5.59.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 151
 
 5.60 OmniBiome Therapeutics Inc. Company Overview 152
 
 5.60.1 OmniBiome Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
 
 5.61 One Way Liver Genomics, S.L. Company Overview 153
 
 5.61.1 One Way Liver Genomics, S.L. Pipeline Products & Ongoing Clinical Trials Overview 153
 
 5.62 OPKO Health, Inc. Company Overview 155
 
 5.62.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 155
 
 5.63 Oxford Gene Technology Limited Company Overview 157
 
 5.63.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 157
 
 5.64 Oxford Immunotec Limited Company Overview 159
 
 5.64.1 Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview 159
 
 5.65 Pediatric Bioscience, LLC Company Overview 161
 
 5.65.1 Pediatric Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 161
 
 5.66 Progentec Diagnostics, Inc. Company Overview 162
 
 5.66.1 Progentec Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
 
 5.67 Protagen AG Company Overview 163
 
 5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 163
 
 5.68 ProteinLogic Ltd Company Overview 170
 
 5.68.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 170
 
 5.69 Quanterix Corporation Company Overview 171
 
 5.69.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 171
 
 5.70 Regulus Therapeutics Inc. Company Overview 173
 
 5.70.1 Regulus Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 173
 
 5.71 Rice University Company Overview 175
 
 5.71.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 175
 
 5.72 Roche Diagnostics International Ltd. Company Overview 177
 
 5.72.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 177
 
 5.73 Shuwen Biotech Co. Ltd. Company Overview 181
 
 5.73.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 181
 
 5.74 Singulex, Inc. Company Overview 182
 
 5.74.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
 
 5.75 SomaLogic, Inc. Company Overview 183
 
 5.75.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 183
 
 5.76 Southern Illinois University Carbondale Company Overview 184
 
 5.76.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 184
 
 5.77 SQI Diagnostics Inc. Company Overview 186
 
 5.77.1 SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
 
 5.78 The Johns Hopkins University Company Overview 192
 
 5.78.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 192
 
 5.79 The Walter and Eliza Hall Institute of Medical Research Company Overview 194
 
 5.79.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 194
 
 5.80 TheraDiag SA Company Overview 195
 
 5.80.1 TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 195
 
 5.81 Thermo Fisher Scientific Inc. Company Overview 197
 
 5.81.1 Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
 
 5.82 Toscana Biomarkers Srl Company Overview 214
 
 5.82.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 214
 
 5.83 Univalue Valorizacion, S.L. Company Overview 218
 
 5.83.1 Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview 218
 
 5.84 University of California, San Francisco Company Overview 219
 
 5.84.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 219
 
 5.85 University of Chicago Company Overview 221
 
 5.85.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 221
 
 5.86 University of Colorado Company Overview 222
 
 5.86.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 222
 
 5.87 University of Florida Company Overview 223
 
 5.87.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 223
 
 5.88 University of Manchester Company Overview 224
 
 5.88.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 224
 
 5.89 University of Oxford Company Overview 226
 
 5.89.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 226
 
 5.90 University of Pecs Company Overview 229
 
 5.90.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 229
 
 5.91 University Rovira i Virgili Company Overview 230
 
 5.91.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 230
 
 5.92 US Biomarkers, Inc. Company Overview 231
 
 5.92.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 231
 
 5.93 Washington University in St. Louis Company Overview 233
 
 5.93.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 233
 
 5.94 XAir Diagnostics B.V. Company Overview 234
 
 5.94.1 XAir Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview 234
 
 5.95 XEPTAGEN SpA Company Overview 236
 
 5.95.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 236
 
 5.96 Yale University Company Overview 238
 
 5.96.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 238
 
 6 Auto-Immune Diseases- Recent Developments 239
 
 7 Appendix 270
 
 7.1 Methodology 270
 
 7.2 About GlobalData 272
 
 7.3 Contact Us 273
 
 7.4 Disclaimer 273


List Of Tables

 Table 1: Auto-Immune Diseases - Pipeline Products by Stage of Development 20
 
 Table 2: Auto-Immune Diseases - Pipeline Products by Territory 21
 
 Table 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path 22
 
 Table 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 23
 
 Table 5: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development 24
 
 Table 6: Auto-Immune Diseases - Pipeline Products by Stage of Development 28
 
 Table 7: Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
 
 Table 10: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview 37
 
 Table 13: Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 38
 
 Table 18: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
 
 Table 23: Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
 
 Table 28: Amdix B.V. Pipeline Products & Ongoing Clinical Trials Overview 44
 
 Table 31: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 46
 
 Table 34: apDia n.v. Pipeline Products & Ongoing Clinical Trials Overview 47
 
 Table 37: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
 
 Table 48: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
 
 Table 53: BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
 
 Table 56: Biocortech Pipeline Products & Ongoing Clinical Trials Overview 56
 
 Table 59: Biogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
 
 Table 62: Biomedal S.L. Pipeline Products & Ongoing Clinical Trials Overview 59
 
 Table 69: Biomerica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
 
 Table 76: Bionure Farma, S.L. Pipeline Products & Ongoing Clinical Trials Overview 65
 
 Table 79: Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
 
 Table 82: BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
 
 Table 85: Boston University Pipeline Products & Ongoing Clinical Trials Overview 69
 
 Table 88: CareDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
 
 Table 91: CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
 
 Table 94: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
 
 Table 99: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
 
 Table 102: Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
 
 Table 109: Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 79
 
 Table 116: Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
 
 Table 119: Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 83
 
 Table 124: Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
 
 Table 127: Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview 87
 
 Table 130: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
 
 Table 133: Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
 
 Table 138: GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview 92
 
 Table 141: Glycominds Ltd. Pipeline Products & Ongoing Clinical Trials Overview 94
 
 Table 144: Grifols, S.A. Pipeline Products & Ongoing Clinical Trials Overview 95
 
 Table 147: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 97
 
 Table 150: Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 98
 
 Table 153: HOB Biotech Group Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 99
 
 Table 156: Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 100
 
 Table 159: Hycor Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
 
 Table 164: Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
 
 Table 171: ImmusanT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
 
 Table 174: Innobiochips Pipeline Products & Ongoing Clinical Trials Overview 107
 
 Table 177: INOVA Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
 
 Table 196: Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 115
 
 Table 199: Is Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 117
 
 Table 202: LineaGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
 
 Table 205: Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 119
 
 Table 208: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
 
 Table 217: Max-Delbruck-Centrum fur Molekulare Medizin (MDC) Pipeline Products & Ongoing Clinical Trials Overview 125
 
 Table 220: Medica Corporation Pipeline Products & Ongoing Clinical Trials Overview 127
 
 Table 227: Metabolomic Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
 
 Table 236: Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 133
 
 Table 239: MSDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
 
 Table 248: Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
 
 Table 251: Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141
 
 Table 254: Neuro Vigor, LLC Pipeline Products & Ongoing Clinical Trials Overview 143
 
 Table 257: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 144
 
 Table 262: NoToPharm s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 146
 
 Table 277: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 151
 
 Table 280: OmniBiome Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
 
 Table 283: One Way Liver Genomics, S.L. Pipeline Products & Ongoing Clinical Trials Overview 153
 
 Table 286: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 155
 
 Table 289: Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 157
 
 Table 292: Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview 159
 
 Table 295: Pediatric Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 161
 
 Table 298: Progentec Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
 
 Table 301: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 163
 
 Table 320: ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 170
 
 Table 323: Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 171
 
 Table 326: Regulus Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview 173
 
 Table 329: Rice University Pipeline Products & Ongoing Clinical Trials Overview 175
 
 Table 332: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 177
 
 Table 343: Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 181
 
 Table 346: Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
 
 Table 349: SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 183
 
 Table 352: Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 184
 
 Table 357: SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
 
 Table 374: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 192
 
 Table 379: The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 194
 
 Table 382: TheraDiag SA Pipeline Products & Ongoing Clinical Trials Overview 195
 
 Table 387: Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
 
 Table 432: Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 214
 
 Table 443: Univalue Valorizacion, S.L. Pipeline Products & Ongoing Clinical Trials Overview 218
 
 Table 446: University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 219
 
 Table 451: University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 221
 
 Table 454: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 222
 
 Table 457: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 223
 
 Table 460: University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 224
 
 Table 465: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 226
 
 Table 472: University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 229
 
 Table 475: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 230
 
 Table 478: US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 231
 
 Table 481: Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 233
 
 Table 484: XAir Diagnostics B.V. Pipeline Products & Ongoing Clinical Trials Overview 234
 
 Table 487: XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 236
 
 Table 490: Yale University Pipeline Products & Ongoing Clinical Trials Overview 238
 
 Table 493: Glossary 271


List Of Figures

 Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development 20
 
 Figure 2: Auto-Immune Diseases - Pipeline Products by Territory 21
 
 Figure 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path 22
 
 Figure 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date 23


Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015

“Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015 provides an overview of Auto-Immune Diseases currently in pipeline stage.    The report provides comprehensive information on the pipeline products with comparative

USD 4000View Report

The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The National Institute of Allergy and Infectious Diseases (NIAID) a subsidiary of National Institutes of Health is a research institute that provides technological and therapeutic solutions. The institute develops therapies,

USD 250View Report

New Technologies Initiative: Gateway to Treating Genetic Diseases - Sarepta Therapeutics - Skipping Makes Sense - Restoring Muscle Function in Duchenne Muscular Dystrophy

Approval of KYNAMRO (ISIS/Sanofi, HoFH), a first systemic Oligonucleotide Antisense (ASO) based therapy has raised expectations from the compounds in pipeline of other companies with similar technology platforms. Highly differentiated,

USD 500View Report

U.S. Army Medical Research Institute of Infectious Diseases - Medical Equipment - Deals and Alliances Profile

U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is a healthcare company, based in the US. The company conducts research activities on infectious diseases. It develops vaccines

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 4000
  • Site Licence    $ 8000
  • Enterprise Wide Licence    $ 12000
$ 4000

Reports Details

Published Date : Jan 2016
No. of Pages :273
Country :Global
Category :Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment